(ZH) 80% Of Michael Burry's 13F Is Palantir And Nvidia Puts

80% Of Michael Burry's 13F Is Palantir And Nvidia Puts

One day before Halloween (perhaps he would have been better served to wait a few hours for give it a spookier, Oct 31 post date), the "Big Short" Michael Burry emerged from his periodic X/Twitter hibernation, where he tends to nuke his account every so often, only to reemerge several months later, with a cryptic post in which he references both the classic movie WarGames, and the movie Big Short (in which Christian Bale plays him). It said "Sometimes, we see bubbles. Sometimes, there is something to do about it. Sometimes, the only winning move is not to play."
He followed it up with another post earlier today, which hinted that - as Goldman first did last summer - the return on AI was just too little, and like the early days of the dot com bubble when there was a massive overspending on fiber capex, so too many of the leading companies of the current AI bubble would crash and burn.
And then something interesting happened: Burry's Scion Asset Management published its 13F some two weeks early, and revealed that Burry not only sees a bubble, but is doing something about it.
Half of the 13F was boring: mostly small legacy positions including Bruker, Lululemon (which has suffered a spectacular collapse this year), as well as SLM and Molina Healthcare.
However, the other half was interesting, first - because it was entirely in the form of puts and calls, and second - because the puts were for Palantir and Nvidia, the two companies that define the AI bubble. And not any puts, but very large puts (for Burry's AUM) - the notional equivalent value for the Palantir puts was a whopping $912 million (equivalent to 5mm shares), while his Nvidia Put was worth a notional equivalent $186 million.
Unfortunately, we don't know either how much premium Burry actually paid or the actual terms of the puts including strike price and maturity.
All we know is that Burry appears to once again be swinging for the bubble fences, similar to what he did during the housing bubble, and is shorting the two names that are most synonymous with the current market mania, similar to what he did in 2008 when he was shorting housing using CDS.
We also know that since both names are sharply higher than where they were on Sept 30 (the date of the 13F), Burry has already suffered substantial losses on his positions, assuming he hasn't already liquidated them (at a loss).
And while some will declare that Burry putting his money where his bubble-bursting mouth is, is a sign of the top, we have two words of caution: back in 2005, Burry was early by about 2 years, and even though he ultimately got the trade right, the carry on the CDS crushed him.
Second, the last time Burry tried to top tick the market was January 2023 when he blasted the one-word "Sell."
The market is up 69% since then.

TechCrunch : Elad Gil on which AI markets have winners — and which are still wid

Elad Gil on which AI markets have winners — and which are still wide open

Solo VC investor extraordinaire Elad Gil said onstage at TechCrunch Disrupt 2025 that AI has been one of the least predictable tech booms he’s ever seen.

Gil is on the cap table of virtually every hit company of the past decade, including many of today’s leading AI companies.

Still, he thinks that over the last year, certain AI markets appear to be nearly sewn up by market leaders. Beyond these areas, a vast swath of AI remains anyone’s game.

“I started investing in generative AI in 2021 … [A]t the time, not very many people were paying that much attention to it,” Gil said. But he had seen the massive leap in capability between GPT-2, launched in 2019, and GPT-3, launched in 2021. “The step between 2 and 3 was so large that if you just extrapolated out the scaling laws, or the curve, then you could really assume that this was going to be incredibly important,” he said.

That convinced him to start backing early-stage startups building products powered by large language models. His bets included both foundational model makers like OpenAI and Mistral, as well as application companies like Perplexity, Harvey, Character.ai, Decagon, and Abridge. Yet throughout 2024 and much of 2025, the capabilities of foundational models leaped with every release, upending AI every few months.

“I used to say at the time that AI was the one market where the more I learn, the less I know. Usually, the more you learn about something, the better you know it, the easier you can predict the future, etc. But AI was just hazy. There’s just too much uncertainty. And I think there’s still markets like that in AI,” he said.

However, he’s also now seeing markets with clear winners. The most obvious example is with foundational models themselves. Even though hundreds of models exist, and some countries like South Korea are still working to develop sovereign models by local companies, leaders have emerged. “Google, Anthropic, OpenAI, maybe xAI, maybe Meta, maybe Mistral — it’s like a handful,” he predicts of the winners.

After models, he thinks AI-assisted coding has runaway winners that will make it hard for new entrants to catch up. Not only have the foundational model makers moved in (Anthropic with Claude Code, OpenAI with Codex) but also startup leaders like Anysphere’s Cursor and Cognition’s Devin (which acquired Windsurf) will be hard to beat. And there are well-funded startups like Magic (which Gil called a possible “outlier”) and Poolside on their tails.

He sees medical transcription as being cornered, with Abridge a front-runner and a handful of others like Ambience being “important.”

He names customer support — which was an early target of both traditional AI and the new crop of AI agent startups — as having hard-to-catch market leaders, such as his portfolio company Decagon. (It raised $131 million at a $1.5 billion valuation in June.) OpenAI chairman Bret Taylor’s startup, Sierra, competes in this space. This is also an area where the incumbents — Salesforce, HubSpot, and many others — are adding AI offerings.

So which markets seem wide open? Gil says financial tooling (fintech), accounting, AI security, and “other markets that we know are by default very interesting. We just don’t know who’s going to do it.”

Ironically, fast growth isn’t the signal it once was that a company is going to be a breakout hit. “The CEOs of every big company are basically telling their teams, hey, we have an edict. We need to figure out our AI strategy,” Gil said. “These giant enterprises are willing to try things that two years ago they never would have tried, and it’s only because of AI.”

So new AI markets can land a lot of revenue from big-name, enterprise customers quickly, “but that doesn’t mean they’re going to stick,” Gil points out.

It is only after a market goes through its trial-phase boom cycle that a startup and investors can see if this revenue will stay and grow. “There’s false signal, and then there’s stuff that is just working,” Gil said. He calls out legal AI startup Harvey as one of the market leaders that’s “just working.” It raised three massive rounds in 2025, leaping from a $3 billion valuation to $5 billion to $8 billion, in just a few months.

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • TCMD +23%, UPWK +19%, SGHC +13.8%, KFRC +12.1%, INVX +10.8%, DAVE +10%, SANM +9.9%, PAY +9.8%, FWRG +9.8%, EXAS +9.2%, LTH +9%, HSIC +8.1%, CPRI +6.7%, GPN +6.5%, FN +6.1%, JBTM +5.9%, AUDC +5.9%, SXC +5.5%, EVER +5.3%, MDGL +5%, INSP +4.8%, AHCO +4.8%, AUPH +4.4%, YUMC +4%, GENI +3.9%, VVX +3.5%, CRVL +3.4%, HOG +3.4%, SLAB +3.4%, SPOT +3.3%, STRL +3%, PHG +2.9%, APO +2.9%, ACLS +2.7%, OFIX +2.7%, CLX +2.5%, PJT +2.5%, BRSL +2.3%, SHC +2.3%, YUM +2.2%, ORA +2.1%, FOLD +2.1%, CMRE +2.1%, BCC +1.9%, GT +1.7% (also completes divestiture of Goodyear Chemical business), IT +1.7%, VNO +1.6%, RACE +1.5%, MPLX +1.5%, COMP +1.5%, PCH +1.3%, IIPR +1%
Other news:
  • DENN +49.6% (to be acquired by TriArtisan Capital Advisors; also reported earnings)
  • PRLD +9.8% (announces an exclusive option agreement with Incyte (INCY) focused on Prelude's previously undisclosed mutant selective JAK2V617F JH2 inhibitor program in development for patients with myeloproliferative neoplasms)
  • FULC +5.1% (to present data from PIONEER trial of Pociredir)
  • PLX +2.5% (seeks re-examination for Elfabrio)
  • YUM +2.2% (partners with Optimus Energy to bring EV stations to Saucy locations)
  • MSBI +2.1% (authorizes new $25 mln share repurchase program)
  • GVA +1.9% (awarded $70 mln contract by the Tucson Airport Authority)
  • VALN +1.8% (reports Phase 1 results for second-generation Zika vaccine candidate)
  • AIR +1.6% (acquires HAECO Americas from HAECO Group)
  • SITC +1.5% (sale of Parker Pavilions for $8.4 mln)
  • DXPE +1% (completes acquisition of Triangle Pump & Equipment)

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • SRPT -39.3%, JELD -33.3% (also workforce reductions and strategic actions), ICHR -28%, NSP -27.4%, NVTS -18%, SHLS -16.3%, AESI -15.6% (suspends quarterly dividend; also places order of 240 MW power generation equipment), TEF -11%, UUUU -9.8%, BWXT -9.2%, NCLH -8.6%, ADM -8.5%, MPC -8.1%, ZTS -7.9%, ADTN -7.2%, PLTR -7.1%, IAC -6.8%, FMS -6.8%, MYGN -6.5%, CBT -6.2%, GRAB -5.5%, ETN -4.9%, GPK -4.3%, UBER -4.1%, VRTX -4%, SNDX -4%, BEAM -4%, RNG -3.9%, AMRC -3.8%, OTTR -3.8%, SWK -3.7%, TRI -3.7%, INGR -3.6%, XENE -3.5% (also appoints CFO), SQNS -3.5%, LUNR -3.4%, SHOP -3.4%, PRIM -3.3%, VOYG -3%, KYMR -3%, SLDB -2.7%, TDUP -2.5%, LSCC -2.5%, HUT -2.5%, QRVO -2.4%, VTLE -2.3% (also provides merger update), APLE -2.3%, VNOM -2.2%, SEI -2.1%, OGS -2%, VTS -2%, UMH -2%, PLOW -2%, ADT -2%, MARA -1.7%, CNO -1.5%, UNM -1.3%, CRK -1.2%, SEE -1.1%, FNV -1%, GTM -1%, EMBJ -1%
Other news:
  • MX -9.3% (concludes agreement with Hyundai (HYMLF) Mobis Company Limited)
  • ARDX -7.4% (files mixed securities shelf offering)
  • ALM -4.4% (commences large-scale drilling program at Panasqueira Mine)
  • WRD -3.9% (pricing of its global offering of 88,250,000 Class A ordinary shares of the Company, which comprises an international offering and a Hong Kong public offering)
  • MSTR -2.8% (intends to conduct initial public offering)
  • HURA -1.6% (files for $250 mln mixed shelf offering; also stock offering by selling shareholders, relates to warrants)
  • CODI -1.3% (secured lender group extends due date for CODI's restated financial results)
  • EBC -1.2% (completes HarborOne (HONE) acquisition)

>>> US Uber reports Q3 (Sep) results, beats on revs, gross bookings up 21%, at u

Uber reports Q3 (Sep) results, beats on revs, gross bookings up 21%, at upper end of prior guidance range; Guides Q4 Gross Bookings above consensus, adjusted EBITDA in-line (99.72)
  • Reports Q3 (Sep) earnings of $3.11 per share, may not be comparable to the FactSet Consensus of $0.69; revenues rose 20.4% year/year to $13.47 bln vs the $13.28 bln FactSet Consensus.
  • Net income attributable to Uber Technologies was $6.6 billion, which includes a $4.9 billion benefit from a tax valuation release.
  • Adjusted EBITDA grew 33% yr/yr to $2.3 billion, above prior guidance of $2.19-$2.29 bln.
  • Gross Bookings grew 21% yr/yr to $49.7 billion, or 21% on a constant currency basis, at the upper end of $48.25-$49.75 bln prior guidance
  • Trips during the quarter grew 22% year-over-year to 3.5 billion, driven by Monthly Active Platform Consumers growth of 17% YoY and monthly Trips per MAPC growth of 4% YoY.
  • Guidance: Sees Q4 Gross Bookings of $52.25-$53.75 bln, above the $52.1 bln FactSet Consensus estimate; Sees adjusted EBITDA of $2.41-$2.51 bln, in-line with the $2.47 bln FactSet Consensus estimate.

>>> Europe : Brokers Upgrades & Downgrades - 4th of November 2025 V3(++)

>>> Up
* Academedia Raised to Buy at ABG; PT 125 kronor
* Aker Solutions Raised to Buy at Fearnley; PT 38 kroner
* Aker Solutions Raised to Hold at Danske Bank Markets (++)
* Allianz Tech Raised to Buy at Stifel (+)
* Apple Raised to Buy at DZ Bank; PT $300
* AT&S Raised to Buy at Erste Group; PT 40 euros
* Comcast Raised to Neutral at BNPP Exane; PT $28
* Fortum Raised to Neutral at BNPP Exane; PT 18.50 euros
* Fractal Gaming Group Raised to Buy at ABG; PT 43 kronor
* Huber+Suhner PT Raised to 172 Swiss francs at Berenberg
* Lea Bank Raised to Buy at Pareto Securities; PT 14.50 kronor (+)
* Moncler Raised to Overweight at Barclays; PT 61 euros
* Polar Capital Tech Raised to Buy at Stifel (+)
* Proximar Seafood Raised to Buy at Norne Securities; PT 1 krone (++)
* Rentokil PT Raised to 300 pence from 284 pence at Berenberg
* Ryanair Raised to Buy at Peel Hunt; PT 30.75 euros
* Selvita Raised to Outperform at Santander Biuro Maklerskie (+)
* Sobi Raised to Buy at Deutsche Bank; PT 370 kronor
* Technip Energies Raised to Buy at Fearnley; PT 46 euros (+)
* TKH GDRs PT Raised to 55 euros from 40 euros at Berenberg
* Unibail Raised to Buy at BofA; PT 105 euros (+)

>>> Down
* Aasen Sparebank Cut to Hold at Norne Securities; PT 136 kroner
* AbbVie Cut to Hold at DZ Bank; PT $237
* Aspo Cut to Accumulate at Evli Bank; PT 7.10 euros (+)
* Deutsche PBB Cut to Reduce at Kepler Cheuvreux; PT 4 euros (+)
* Givaudan Cut to Reduce at AlphaValue/Baader
* Hermes Cut to Equal-Weight at Barclays; PT 2,310 euros
* Ilkka Oyj Cut to Accumulate at Inderes; PT 4.50 euros
* Italgas Cut to Neutral at Intesa Sanpaolo; PT 9.70 euros (+)
* Next Cut to Hold at Shore Capital
* Nokia Cut to Hold at Danske Bank Markets; PT 6.50 euros (++)
* Sika PT cut from 285 to 240 CHF at Berenberg
* Sparebank 68 Grader Nord Cut to Hold at Norne Securities
* Straumann Raised to Neutral at UBS; PT 102 Swiss francs (++)
* Tecnicas Reunidas Cut to Neutral at JB Capital Markets
* UBS Cut to Neutral at BNPP Exane; PT 32 Swiss francs
* uniQure Cut to Neutral at Van Lanschot Kempen; PT $30
* X-Fab Silicon Foundries Cut to Hold at Deutsche Bank; PT 6 euros

>>> Initiation
* Amrize Rated New Neutral at Oddo BHF; PT 42 Swiss francs
* Asmodee Reinstated Outperform at BNPP Exane; PT 160 kronor
* Capgemini Resumed Buy at Citi; PT 170 euros
* Eli Lilly Reinstated Buy at William O'Neil
* NP3 Fastigheter Rated New Buy at SEB Equities; PT 306 kronor
* SigmaRoc Rated New Hold at Berenberg; PT 120 pence

>>> Call
* Deutsche PBB Downgraded at Kepler, Target Cut to Street-Low (+)
* Fresenius Medical Drops; Citi Notes Lackluster Treatment Growth (++)
* Ryanair Raised at Peel Hunt on Lower Costs, Constrained Supply

>>> Europe : Brokers Upgrades & Downgrades - 4th of November 2025 V2(+)

>>> Up
* Academedia Raised to Buy at ABG; PT 125 kronor
* Aker Solutions Raised to Buy at Fearnley; PT 38 kroner
* Allianz Tech Raised to Buy at Stifel (+)
* Apple Raised to Buy at DZ Bank; PT $300
* AT&S Raised to Buy at Erste Group; PT 40 euros
* Comcast Raised to Neutral at BNPP Exane; PT $28
* Fortum Raised to Neutral at BNPP Exane; PT 18.50 euros
* Fractal Gaming Group Raised to Buy at ABG; PT 43 kronor
* Huber+Suhner PT Raised to 172 Swiss francs at Berenberg
* Lea Bank Raised to Buy at Pareto Securities; PT 14.50 kronor (+)
* Moncler Raised to Overweight at Barclays; PT 61 euros
* Polar Capital Tech Raised to Buy at Stifel (+)
* Rentokil PT Raised to 300 pence from 284 pence at Berenberg
* Ryanair Raised to Buy at Peel Hunt; PT 30.75 euros
* Selvita Raised to Outperform at Santander Biuro Maklerskie (+)
* Sobi Raised to Buy at Deutsche Bank; PT 370 kronor
* Technip Energies Raised to Buy at Fearnley; PT 46 euros (+)
* TKH GDRs PT Raised to 55 euros from 40 euros at Berenberg
* Unibail Raised to Buy at BofA; PT 105 euros (+)

>>> Down
* Aasen Sparebank Cut to Hold at Norne Securities; PT 136 kroner
* AbbVie Cut to Hold at DZ Bank; PT $237
* Aspo Cut to Accumulate at Evli Bank; PT 7.10 euros (+)
* Deutsche PBB Cut to Reduce at Kepler Cheuvreux; PT 4 euros (+)
* Givaudan Cut to Reduce at AlphaValue/Baader
* Hermes Cut to Equal-Weight at Barclays; PT 2,310 euros
* Ilkka Oyj Cut to Accumulate at Inderes; PT 4.50 euros
* Italgas Cut to Neutral at Intesa Sanpaolo; PT 9.70 euros (+)
* Next Cut to Hold at Shore Capital
* Sika PT cut from 285 to 240 CHF at Berenberg
* Sparebank 68 Grader Nord Cut to Hold at Norne Securities
* Tecnicas Reunidas Cut to Neutral at JB Capital Markets
* UBS Cut to Neutral at BNPP Exane; PT 32 Swiss francs
* uniQure Cut to Neutral at Van Lanschot Kempen; PT $30
* X-Fab Silicon Foundries Cut to Hold at Deutsche Bank; PT 6 euros

>>> Initiation
* Amrize Rated New Neutral at Oddo BHF; PT 42 Swiss francs
* Asmodee Reinstated Outperform at BNPP Exane; PT 160 kronor
* Capgemini Resumed Buy at Citi; PT 170 euros
* Eli Lilly Reinstated Buy at William O'Neil
* NP3 Fastigheter Rated New Buy at SEB Equities; PT 306 kronor
* SigmaRoc Rated New Hold at Berenberg; PT 120 pence

>>> Call
* Deutsche PBB Downgraded at Kepler, Target Cut to Street-Low (+)
* Ryanair Raised at Peel Hunt on Lower Costs, Constrained Supply

>>> What to look at today - 4th of November 2025

US stock futures dropped along with Asian shares as uncertainty over the Federal Reserve’s policy outlook and Palantir Technologies Inc.’s earnings weighed on sentiment. Contracts for the S&P 500 fell 0.5% after the underlying index posted a modest gain Monday, even as more than 300 of its members retreated. Nasdaq 100 futures fell 0.7%, with Palantir declining more than 4% in extended trading on concerns about the company’s lofty valuation after a record run-up. Futures also indicated a weaker open for European shares.  Asian equities dropped 0.6%, while in South Korea, the regulator issued an unusual “investment caution” on SK Hynix Inc. shares after its 240% rally. A gauge of the dollar extended its gains to a fifth day after the greenback strengthened against most of the Group-of-10 currencies, trading at levels last seen in August. The advance came amid mixed signals from Fed officials, following Chair Jerome Powell’s warning last week that a rate cut in December isn’t a foregone conclusion. A flurry of US central bank officials offered contrasting views on the outlook for further rate cuts, with Chicago Fed President Austan Goolsbee saying he’s more concerned about inflation than the job market. Even as US factory activity contracted for an eighth straight month in October, global stocks hovered near record highs, driven by technology heavyweights and stoking calls for broader-market consolidation. The Institute for Supply Management’s manufacturing index eased 0.4 point to 48.7, according to data released Monday. Readings below 50 indicate contraction, and the measure has been stuck in a narrow range for most of this year. Economists and policymakers are relying more on private reports such as the ISM survey for clues on the economy and job market in the absence of official data because of the US government shutdown. Friday’s scheduled employment report is also poised to be delayed as a result. Gold edged lower for a third consecutive session. Treasuries steadied, while oil fell as the market weighed OPEC+’s decision to pause output hikes. Elsewhere, shares in Australia extended their losses and the currency fell after the central bank held its benchmark rate unchanged. India’s rupee gained, pulling back from a near-record low after likely interventions by the Reserve Bank of India.  Earlier, Fed Governor Lisa Cook said she sees the risk of further labor-market weakness as greater than the chance that inflation will pick up. She stopped short of endorsing another interest-rate cut next month. Her comments echoed remarks from her colleagues who were equally noncommittal about whether the central bank should deliver a third straight rate reduction when policymakers convene in December. San Francisco Fed President Mary Daly said officials should “keep an open mind” about the possibility of a December cut. Governor Stephen Miran noted policy remains restrictive.  Back to Palantir, the company raised its annual revenue outlook to $4.4 billion and outpaced analyst estimates for third-quarter sales. Investors have sent the firm’s shares up more than 150% so far this year, closing Monday at a record $207.18. The company had a price-to-sales ratio of 85 as of Friday — the highest in the S&P 500 Index.  Mandeep Singh, senior analyst at Bloomberg Intelligence, said that investors likely wanted more guidance about the following year. Palantir gave a forecast for the current quarter, Singh said, but everyone wanted some sense of 2026, he said. The market reaction highlights “how stretched expectations are in the AI space,” Chanana said. “A small post-print dip says more about lofty expectations than fundamentals.” US After Hours FN +9.8%, HIMS +5.4% higher on earnings; DENN +47.4% surging on news it's to be acquired by TriArtisan Capital; SRPT -39.1% under pressure after earnings; PLTR -2% heading lower on earnings.

Nikkei -1.74% Hang Seng -0.84% CSI -1.08% Shanghai -0.77% Shenzen -1.74%

Eur$ 1.1510 CNH 7.1319 CNY 7.1272 JPY 153.80 GBP 1.3124 CHF 0.8091 RUB 81.0000 TRY 42.0710 WTI$ 60.86 -0.31% Gold 3,983 -0.49% BTC 105,460 -1.33% ETH 3,535 -1.89%

S&P -0.87% Nasdaq -1.21% EuroStoxx -0.92% FTSE -0.31% Dax -0.99% SMI -0.58%

Macro :
- Italy Oct. New Car Sales Fall 0.57% Y/y
- Yardeni Warns ‘Too Many Bulls’ Put Stocks on Cusp of a Pullback
- Travel Industry Sounds Alarm Over Government Shutdown - WSJ
- US Sees Air Safety Risks as Government Shutdown Hurts Flying
- China Regions Cut Power Bill to Datacenters With Local Chips: FT
- China Envoy Warns US Against Creating New Troubles After Summit
- UBP Is Latest Private Bank Setting Up Office in Saudi Arabia
- *SERBIA GOLD RESERVES TO ALMOST DOUBLE TO 100T BY 2030: VUCIC

Keep an eye on :
- ABF LN : AB Foods FY Adjusted Operating Profit Beats Estimates
- AKER NO : Aker 3Q NAV per Share NOK909 Vs. NOK895 Q/Q; Sees Leverage Rise
- ALC SW : Alcon Urges STAAR to Accept Offer to Amend Merger Agreement
- ATS AV : AT&S Sees FY Revenue About EU1.7B, USD May Impact 26/27 Goal
- AYV FP : Ayvens Backers Offer Stake Worth $1.1 Billion in Leasing Firm
- BAKKA NO : Bakkafrost 3Q Operating Ebit Misses Estimates
- BMPS IM : Caltagirone Gets ECB OK to Raise Paschi Stake Up to 20%: Stampa
- BMW GY : BMW Ventures shares are trading higher after securing an order worth ₹4.49 crore to fabricate and supply bow string girders in
- BSLN SW : Basilea Cresemba Europe Sales Trigger $30m Milestone Payment
- BELL SW : Bell Food Group Buys Cured Ham Producer Hermann Wein; No Terms
- BEN FP : Beneteau 3Q Sales at Constant Exchange Rates -3%
- BETA US : IPO : Electric Plane Maker Beta Technologies Raises $1 Billion in IPO
- BIM FP : BioMerieux Cuts FY Organic Sales Forecast
- BOOZT SS : Boozt Boosts FY Adjusted Ebit Margin Forecast
- BP/ LN : BP 3Q Adjusted Ebit Beats Estimates
- BCHN SW : Burckhardt 1H Ebit CHF65.5M Vs. CHF67.0M Y/y
- CPR IM : Lagfin Says 214m Campari Shares Seized, Tax Probe ‘Unfounded’
- CIBUS SS : Cibus Nordic Real Estate 3Q Rental Income EU42.0M
- CLX US : Clorox 1Q Adjusted EPS Beats Estimates
- COLOB DC : Coloplast 4Q Revenue Misses Estimates, Coloplast Sees 2026 Organic Revenue About +7%, Est. +7.49%
- COR PL : Corticeira Amorim 9M Net Income EU45.7M Vs. EU47.8M Y/y
- DEME BB : DEME, Aspiravi, Qair Make Ownership Changes in ScotWind Project
- DENN US : Denny’s Corporation to be Acquired by TriArtisan Capital Advisors, Treville Capital Group and Yadav Enterprises in $620
- EDEN FP : Edenred Presents Strategic Plan Aiming at >€5B Revenue in 2030
- LLY US : Eli Lilly calls on Europe to ditch clawback taxes on drugmakers
- EVK GY : Evonik 3Q Adjusted Ebitda Misses Estimates
- FLUO SS : Fluoguide Offers SEK100 million Shares, Fluoguide Offering of 2.7m Shares Prices at SEK38/Share
- FME GY : Fresenius Medical Care 3Q Oper Income Excl Special Items EU574M
- GEBN SW : Geberit 3Q Ebitda Misses Estimates, Geberit Boosts FY Sales Forecast
- GF SW : Georg Fischer Targets Sales of CHF4.2B to CHF4.5B by 2030
- GT US : Goodyear 3Q Net Sales Match Estimates
- GRAB US : Grab Holdings Boosts FY Adj. Ebitda Forecast, Beats Estimates
- HALO US : Halozyme Boosts FY Revenue Forecast
- HIMS US : Hims & Hers Health 3Q Revenue Beats Estimates
- HOLX US : Hologic 4Q Adjusted EPS $1.13, Est. $1.10
- BOSS GY : Hugo Boss Sees FY Ebit Low End of EU380M to EU440M
- ILTY IM : Banca Sella to Buy 50% Illimity’s Hype Stake for EU85M
- IPCO SS : IPC 3Q Revenue Beats Estimates
- KMB US : Kimberly-Clark Tanks on Deal to Buy Tylenol Maker Kenvue
- KIN BB : Kinepolis Buys Emagine at Transaction Value of $105M
- LSCC US : Lattice Falls as Adj. Gross Margin Forecast Misses Estimates
- LTMC IM : Lottomatica FY Adjusted Ebitda Forecast Meets Estimates
- MMK AV : Mayr-Melnhof 9M Net Income EU166.5M Vs. EU52.3M Y/y
- META US : Threads Passes X In Key Monthly Metric For First Time In Zuckerberg Vs. Musk Battle
- MSFT US : Lambda Reports Multibillion-Dollar Agreement With Microsoft
- NVTS US : Navitas Semiconductor 3Q Adj Loss/Shr 5.0C, Est. Loss/Shr 5.0C
- NEM GY : Nemetschek 3Q Ebitda Beats Estimates
- Nexperia : China Urges Netherlands to Constructively Solve Nexperia Dispute
- NOKIA FH : Nokia to Seek Delisting From Paris Stock Exchange
- NDX1 GY : Nordex 3Q Sales Miss Estimates
- NOEJ GY : Norma 3Q Adjusted Ebit EU3.8M Vs. EU7.5M Y/y
- NB2 GY : Northern Data Sells Mining Unit For Up to $200m
- NOVOB DC : Novo Nordisk's weight-loss drug Wegovy could soon have a new sales outlet in the U.S.
- OERL SW : Oerlikon 3Q Orders CHF396M Vs. CHF376M Y/y, OC Oerlikon Places CHF350 Million Unsecured Bonds
- OHI US : Omega Healthcare Files for $2 billion Shares ATM Offering
- ORSTED DC : Apollo to Invest $6.5b For 50% Stake In Ørsted’s Hornsea 3
- PL TR US : Palantir Boosts FY Revenue Forecast, Beats Estimates
- PHIA NA : Philips 3Q Adjusted Ebita Beats Estimates, Philips Order Intake Rises 8% on Robust Demand in North America, Philips Reiterates Confidence In Full-Year 2025 Outlook With 1%-3% Comparable Sales Growth, Adjusted EBITA Margin Up To 11.8%,
- QRVO US : Qorvo 2Q Adjusted Revenue Beats Estimates
- SFQ GY : SAF-Holland SE FY Sales Forecast Misses Estimates
- SRPT US : *SAREPTA SHARES DROP 20% AFTER RESULTS, ESSENCE STUDY MISS
- SHEL LN : Keppel, Partners Buy Remaining 49% Stake in Cleantech Renewable
- SPG US : Simon Property 3Q FFO/Share Beats Estimates
- SBUX US : Starbucks Says Boyu to Buy up to 60% in China Retail Operations
- STLA US : Canada to Launch Dispute-Resolution Process to Stop Stellantis Production Move - WSJ
- STLA US : Novonix Says Stellantis Unit Ends Offtake Agreement
- MSTR US : Strategy Plans IPO of Euro-Denominated STRE Preferred Stock
- SSABA SS : SSAB Targets Premium Offering of 65% of Shipments Around 2030
- TEF SM : Telefonica 3Q Revenue Meets Estimates
- UCB BB : UCB Gets FDA Approval for Kygevvi to Treat TK2d
- QURE US : UniQure Tumbles After ‘Surprising’ Pivot by FDA on Drug Data
- VCT FP : Vicat Delivers Small Revenue Beat in Third Quarter, Citi Says
- VNOM US : Viper Energy 3Q Average Price per BOE Misses Estimates
- WHA NA : Wereldhave Narrows FY EPS Forecast, Beats Estimates
- ZLNA NO : Zelluna Offering of 5.5m Shares Prices at NOK10/Share

>>> Europe : Brokers Upgrades & Downgrades - 4th of November 2025

>>> Up
* Academedia Raised to Buy at ABG; PT 125 kronor
* Aker Solutions Raised to Buy at Fearnley; PT 38 kroner
* Apple Raised to Buy at DZ Bank; PT $300
* AT&S Raised to Buy at Erste Group; PT 40 euros
* Comcast Raised to Neutral at BNPP Exane; PT $28
* Fortum Raised to Neutral at BNPP Exane; PT 18.50 euros
* Fractal Gaming Group Raised to Buy at ABG; PT 43 kronor
* Huber+Suhner PT Raised to 172 Swiss francs at Berenberg
* Moncler Raised to Overweight at Barclays; PT 61 euros
* Rentokil PT Raised to 300 pence from 284 pence at Berenberg
* Ryanair Raised to Buy at Peel Hunt; PT 30.75 euros
* Sobi Raised to Buy at Deutsche Bank; PT 370 kronor
* TKH GDRs PT Raised to 55 euros from 40 euros at Berenberg

>>> Down
* Aasen Sparebank Cut to Hold at Norne Securities; PT 136 kroner
* AbbVie Cut to Hold at DZ Bank; PT $237
* Givaudan Cut to Reduce at AlphaValue/Baader
* Hermes Cut to Equal-Weight at Barclays; PT 2,310 euros
* Ilkka Oyj Cut to Accumulate at Inderes; PT 4.50 euros
* Next Cut to Hold at Shore Capital
* Sika PT cut from 285 to 240 CHF at Berenberg
* Sparebank 68 Grader Nord Cut to Hold at Norne Securities
* Tecnicas Reunidas Cut to Neutral at JB Capital Markets
* UBS Cut to Neutral at BNPP Exane; PT 32 Swiss francs
* uniQure Cut to Neutral at Van Lanschot Kempen; PT $30
* X-Fab Silicon Foundries Cut to Hold at Deutsche Bank; PT 6 euros

>>> Initiation
* Amrize Rated New Neutral at Oddo BHF; PT 42 Swiss francs
* Asmodee Reinstated Outperform at BNPP Exane; PT 160 kronor
* Capgemini Resumed Buy at Citi; PT 170 euros
* Eli Lilly Reinstated Buy at William O'Neil
* NP3 Fastigheter Rated New Buy at SEB Equities; PT 306 kronor
* SigmaRoc Rated New Hold at Berenberg; PT 120 pence

>>> Call
* Ryanair Raised at Peel Hunt on Lower Costs, Constrained Supply